4Oshima T,Karasawa F,Satoh T.Effects of propofol on cerebral blood flow and the metabolic rate of oxygen in human[J].Act Anaestheisol Scand,2002,46(7):831-835.
5Sinatra R.Role of Cox-2 inhibitors in the evolution of acute pain management[J].J Pain and Symptom Management,2002,24(1 Suppl):518-527.
6Rosenow DE, Albrechtsen M, Stolke D, et al. A comparison of patientcontrolled analgesia with Lomoxicam versus morphine in patients undergoing lumbar disk surgery. Anesth Analg, 1998,86:1045 ～ 1050.
7Balfour JA, Fitton A, Barradell LB, et al. A review of its pharmacology and therapentic potential in the management of painful and inflammatory conditions. Drugs, 1996,51:639～657.
8McCormack K. Non- steroidal anti - inflammatory drugs and spinal nociceptive processing. Pain , 1994,59:9 ～ 43.
9Pruss TP, Stroissnig H, Radhofer WS, et al. Overview of the pharmacological properties, pharmacokinetics and animal safety assessment of lomoxicam. Postgrad Med J, 1990,66(4) : 18 ～ 21.
10Suwa T, Urano H, Shinohara Y, et al. Simtdtaneous high - performance liquid chromatographic determination of lomoxicam and its 5' - hydroxy metabolite in human plasma using electrochemical detection. J Chromatogr, 1993,617( 1 ) : 105 ～ 111.
